Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Originally developed for type 2 diabetes, these drugs now show promise in treating obesity and conditions like OSA
GLP-1s, which have been used for years to treat type 2 diabetes, have gained widespread attention as a way to lose weight and reduce obesity-related conditions and their long-term costs
, 1999, 25(5): 52-57
Reduced carbohydrate intake and lower glycogen stores can absolutely contribute, especially during higher intensity training
For those individuals prone to obesity, their drive to eat may be more significant, their propensity to increase weight may be higher, and their ability to preserve weight is stronger
fat oxidation and body composition optimization
